PRGO Perrigo shares tick higher despite posting a narrow Q4 2025 EPS miss versus analyst estimates WHWK Whitehawk Therapeutics falls 336 as Q4 2025 EPS misses estimates by a wide 1164 percent margin NMP NMPAR Stock Prediction Whats Next After Recent Move